共 164 条
[21]
Delmas L(1997)Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women N Engl J Med 4 1641-311
[22]
Chen I(1999)The potential of SERMs for reducing the risk of coronary heart disease Trends Endocrinol Metab 10 320-716
[23]
Zeng W(1999)Antiestrogens––tamoxifen, SERMs and beyond Invest New Drugs 17 285-2188
[24]
Xia H(1999)The molecular pharmacology of SERMs Trends Endocrinol Metab 10 301-2005
[25]
Li M(2003)Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat Calcif Tissue Int 72 710-542
[26]
Zhou RD(2005)A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats J Bone Miner Res 20 2178-1181
[27]
Tiegs JJ(2004)Long-term treatment of lasofoxifene preserves bone mass and bone strength and does not adversely affect the uterus in ovariectomized rats Endocrinology 145 1996-1800
[28]
Body HW(1998)Specific bone-protective effects of metabolites/derivatives of tamoxifen and clomiphene in ovariectomized rats Bone 23 537-2288
[29]
Wahner J(1991)Preventetive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat J Bone Miner Res 6 1177-1198
[30]
Barta BL(1997)Clomiphene prevents cancellous bone loss from tibia of ovariectomized rats Endocrinology 138 1794-496